BG News Alert Bunge Limited (BG) 90.02 12/12/2014 22:23:57

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Bunge Limited (BG) 90.02 $BG

Archer Daniels to Establish IT & Support Center in Kentucky - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Dec 12, 10:30AM CST
Archer Daniels Midland Company (ADM), is set to establish its new information technology (IT) and support center in a space within the campus of its WILD Flavors offices in Erlanger, Kentucky.
BG: 90.02 (-2.82), ADM: 49.85 (-1.05), LMNR: 24.60 (-0.40), ANDE: 50.47 (-1.99)

Bunge Set to Possibly Pullback After Yesterday's Rally of 2.77%
Comtex SmarTrend(R) - Thu Dec 11, 4:11PM CST
Bunge (NYSE:BG) traded in a range yesterday that spanned from a low of $91.00 to a high of $93.17. Yesterday, the shares gained 2.8%, which took the trading range above the 3-day high of $93.05 on volume of 1.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BG: 90.02 (-2.82)

Bunge Rises 2.77% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Thu Dec 11, 4:10PM CST
Bunge (NYSE:BG) traded in a range yesterday that spanned from a low of $91.00 to a high of $93.17. Yesterday, the shares gained 2.8%, which took the trading range above the 3-day high of $93.05 on volume of 1.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BG: 90.02 (-2.82)

How Solazyme's Encapso Serves As An Oilfield Enhancer
Kevin Quon - at Seeking Alpha - Tue Dec 09, 10:58AM CST

E: 34.07 (-1.19), BG: 90.02 (-2.82), SZYM: 2.25 (-0.09)

Bunge Limited announces common and preferred stock dividends for quarter
M2 - Fri Dec 05, 6:19AM CST
The board of directors of Bunge Limited (NYSE:BG), an agribusiness and food company, authorised a regular common stock cash dividend of USD0.34 per share for the quarter, the company disclosed on Thursday.
BG: 90.02 (-2.82)

Bunge declares $0.34 dividend
Seeking Alpha - at Seeking Alpha - Thu Dec 04, 4:44PM CST

BG: 90.02 (-2.82)

Bunge Limited Declares Dividends on Common and Preference Shares
PR Newswire - Thu Dec 04, 4:41PM CST
Bunge Limited (NYSE: BG), a global agribusiness and food company, today announced that its Board of Directors has declared a regular quarterly cash dividend of $0.34 per common share. The dividend is payable on March 2, 2015 to shareholders of record on February 17, 2015.
BG: 90.02 (-2.82)

After Yesterday's Decline of 1.61%, Bunge Offers Investors Better Value
Comtex SmarTrend(R) - Thu Dec 04, 4:16PM CST
Bunge (NYSE:BG) traded in a range yesterday that spanned from a low of $89.59 to a high of $91.24. Yesterday, the shares fell 1.6%, which took the trading range below the 3-day low of $90.01 on volume of 1.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
BG: 90.02 (-2.82)

Bunge Set to Possibly Rebound After Yesterday's Selloff of 1.61%
Comtex SmarTrend(R) - Thu Dec 04, 4:15PM CST
Bunge (NYSE:BG) traded in a range yesterday that spanned from a low of $89.59 to a high of $91.24. Yesterday, the shares fell 1.6%, which took the trading range below the 3-day low of $90.01 on volume of 1.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
BG: 90.02 (-2.82)

Bunge Limited to Webcast Investor Day Presentations
PR Newswire - Tue Dec 02, 7:30AM CST
Bunge Limited (NYSE: BG) announced it will webcast presentations given by Bunge's leadership team on December 10, 2014 from 1:00 p.m. EST to 5:00 p.m. EST. A live, listen-only webcast will be available on Bunge's website at www.bunge.com and a replay will be available for the following thirty days.
BG: 90.02 (-2.82)

Archer-Daniels Buys SCI for $191M, Alters Management - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 20, 12:20PM CST
Archer-Daniels (ADM) declared the completion of its buyout of Specialty Commodities.
BG: 90.02 (-2.82), ADM: 49.85 (-1.05), PPC: 33.59 (-2.20), ANFI: 12.00 (-0.16)

Food Products Stocks Technical Analysis - Archer-Daniels-Midland, Bunge, BRF S.A., Chiquita Brands Intl., and Rite Aid
PR Newswire - Tue Nov 18, 8:30AM CST
Investor-Edge has initiated coverage on the following equities: Archer-Daniels-Midland Company (NYSE: ADM), Bunge Ltd (NYSE: BG), BRF S.A. (NYSE: BRFS), Chiquita Brands International Inc. (NYSE: CQB), and Rite Aid Corporation (NYSE: RAD). Free research on these five companies can be accessed at: http://investor-edge.com/register. The US markets on Monday, November 17, 2014, ended on a mixed note as the Dow Jones Industrial Average finished at 17,647.75, up 0.07% and the NASDAQ Composite closed at 4,671.00, down 0.37%. The S&P 500 finished the session 0.07% higher at 2,041.32. During the trading session, four out of ten sectors finished on a higher note. The S&P 500 Consumer Staples Sector Index ended the day at 494.65, up 0.62%, with the index advancing 8.11% in the previous three months. Register for your complimentary reports on these five stocks at:
BG: 90.02 (-2.82), ADM: 49.85 (-1.05), CQB: 14.46 (+0.01), BRFS: 22.00 (-0.54), RAD: 5.69 (+0.06)

Watch for Bunge to Potentially Pullback After Gaining 1.23% Yesterday
Comtex SmarTrend(R) - Mon Nov 17, 5:26PM CST
Bunge (NYSE:BG) traded in a range yesterday that spanned from a low of $88.33 to a high of $89.86. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $89.46 on volume of 1.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BG: 90.02 (-2.82)

After Yesterday's Rally of 1.23% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Mon Nov 17, 5:26PM CST
Bunge (NYSE:BG) traded in a range yesterday that spanned from a low of $88.33 to a high of $89.86. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $89.46 on volume of 1.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BG: 90.02 (-2.82)

Bunge Earnings Review: 18 Days after Announcement Shares Up 3.8% (BG)
Comtex SmarTrend(R) - Mon Nov 17, 7:59AM CST
Two weeks ago on October 30th, 2014 Bunge (NYSE:BG) reported earnings and analysts, on average, expected earnings of $1.90 on sales of $15.2 billion. Bunge actually reported earnings of $1.31 per share on sales of $13.7 billion, missing EPS estimates by $0.59 and missing revenue estimates by $15,174.8 billion. Since the company's report, shares of Bunge have risen from $85.33 to $88.58, representing a gain of 3.8% in the past 18 days.
BG: 90.02 (-2.82)

Archer Daniels Expands in China, Opens Sweetener Facility - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 13, 11:40AM CST
Archer Daniels Midland Company (ADM) inaugurated its previously announced sweetener facility in North China at the port of Tianjin, which overlooks the Yellow Sea.
BG: 90.02 (-2.82), ADM: 49.85 (-1.05), TSN: 40.80 (-0.93), ANFI: 12.00 (-0.16)

Solazyme Repositions Up The Value Chain Amidst Moema's Setback
Kevin Quon - at Seeking Alpha - Sun Nov 09, 10:59PM CST

E: 34.07 (-1.19), BG: 90.02 (-2.82), SZYM: 2.25 (-0.09)

Andersons (ANDE) Plunges as Q3 Earnings Miss Estimates - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 3:20PM CST
The Andersons Inc. (ANDE) plunged 18% on reporting a 3% decline in Q3 earnings to 59 cents per share, way short of the Zacks Consensus Estimate of 76 cents.
BG: 90.02 (-2.82), CZZ: 6.72 (-0.32), LMNR: 24.60 (-0.40), ANDE: 50.47 (-1.99)

Archer Daniels Beats Q3 Earnings, Misses on Revenues - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 11:20AM CST
Archer Daniels Midland Company (ADM) reported better-than-expected adjusted earnings per share for third-quarter 2014.
BG: 90.02 (-2.82), ADM: 49.85 (-1.05), CVGW: 45.37 (-0.49), ANFI: 12.00 (-0.16)

Companies Release Third Quarterly Results - Research Reports on Avon, BorgWarner, Kellogg, Hanes and Bunge
PR Newswire - Tue Nov 04, 8:15AM CST
Today, Analysts Review released its research reports regarding Avon Products, Inc. (NYSE: AVP), BorgWarner Inc. (NYSE: BWA), Kellogg Company (NYSE: K), HanesBrands Inc. (NYSE: HBI) and Bunge Ltd. (NYSE: BG). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7685-100free.
BWA: 52.76 (-0.65), BG: 90.02 (-2.82), AVP: 9.59 (-0.39), HBI: 110.51 (-0.37), K: 65.63 (-1.47)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Baidu Faces Class Action: Investors Push Against Fraud Allegations

Updated Category News Views 2

Baidu Under Fire for Alleged Misleading Statements Here's a fresh slice of drama straight outta the corporate trenches: Baidu, Inc. (NASDAQ: BIDU) finds itself tangled in a securities fraud lawsuit that’s causing a ruckus across investor circles. Schall, Brown & Schwartz LLP, those heavyweight gladiators in shareholder rights, are calling on grieved investors to step up...

Continue Reading
Food Trends Tease: 2027 sofi™ Awards' 75 Finalists

Updated Category News Views 1

The Specialty Food Scene Heats Up Today’s world doesn’t rest when it comes to innovation, and the same goes for the tantalizing realm of specialty foods. Hot off the press, the Specialty Food Association (SFA) just rolled out the red carpet for its 75 finalists in the 2027 sofi™ Awards. These are the future taste shapers set to take center stage at the Winter...

Continue Reading
Kenneth Smith Takes Helm for Trends Int’l Expansion

Updated Category News Views 0

Tired of the Same Old Leadership Shuffle? Here Comes Kenneth Smith Look, I’ve seen my share of execs come and go, usually dragging the same old briefcase of stale ideas. But Kenneth Smith stepping up as CEO of Trends International? Now that’s got some real teeth to it. Come May 2026, he’s the guy at the helm, and he's got one hell of a to-do list. Smith's Roadmap: A...

Continue Reading
LINC Lawsuit: Boardroom Stumbles Spark Investor Action

Updated Category News Views 4

Class Action Kickoff: Lincoln's Educational Curveball No one fancies home runs when the ball’s out of sight, and that’s probably how some investors in Lincoln Educational Services Corporation (NASDAQ: LINC) are feeling right now. A group of shareholders has pulled back the curtain on what they believe are more than just administrative hiccups—allegations of...

Continue Reading
Nest Health Appoints Peter Morrison for Multistate Expansion

Updated Category News Views 3

Peter Morrison Steps Up as Chief Growth Officer You know, it's not every day you see a move as gutsy as Nest Health's recent appointment of Peter Morrison. They're shaking up the Medicaid space, aiming to redefine primary care for families with limited resources. Morrison, coming from heavyweights like UnitedHealthcare and Centene, isn't your typical pencil-pusher. He’s...

Continue Reading
Senté’s Heparan Sulfate Pairing: Peer-Reviewed Success

Updated Category News Views 0

Senté's Science-Driven Approach in Skincare Alright, cutting through the skincare noise, Senté Labs has pulled off something impressive—not just another jar of promises but actual, peer-reviewed science backing their Defense C Serum. Published in the Journal of Cosmetic Dermatology, this study isn't just talk about ingredients; it's a show of real results. This isn't...

Continue Reading
GELITA Showcases Collagen Innovations at SupplySide 2026

Updated Category News Views 11

Collagen Solutions Front and Center First up, a little chat about collagen might be in order. For folks not tied into the science side, it sounds like a trendy wellness potion. But here comes GELITA at SupplySide Global 2026, showing it's the real McCoy. Nestled in Booth #4565, they're laying out a spread of next-gen collagen innovations aimed at everything from wound...

Continue Reading
QFIN Faces Class Action: Investors' Role Explored

Updated Category News Views 0

Cracks in the Facade: QFIN's Legal Mess You're cruising down the usual market lanes when—bam!—news breaks that Qfin Holdings, Inc. (NASDAQ: QFIN) finds itself hip-deep in a class action lawsuit. Seems like our pals at Schall, Brown & Schwartz LLP have thrown the gauntlet down, with claims of some serious smoke and mirrors during the March to August stretch of 2026....

Continue Reading
Kansai Medical Ushers in New Era of Cancer Research

Updated Category News Views 6

Breaking Ground in Cancer Treatment Trials I've seen some thrilling breakthroughs in my time following the pharmaceutical industry, but what Kansai Medical University and Daiichi Sankyo are doing elevates the game. They're rolling out the first patient dose of DS1025 in Osaka, Japan—a move that marks the onset of a global Phase 1 clinical trial. This is no ordinary...

Continue Reading
De¹ Unveils Tokenization Model on BNB Chain

Updated Category News Views 2

De¹'s Bold Move into Enhanced Digital Finance Just when you thought the financial landscape couldn’t get any more complex, De¹ steps into the ring with its Tokenized Asset World on the BNB Chain—a move that's stirring the pot of tokenized finance in more ways than one. For old-school investors who thrive on waving outlandish stock bets, this crypto narrative is a...

Continue Reading

Top 5 Most Recently Viewed Articles

NOV Inc. Announces Scheduled Cash Dividend for Shareholders

Updated Category News Views 124

NOV Inc. Announces Scheduled Cash Dividend for Shareholders HOUSTON — NOV Inc. (NYSE: NOV) is excited to share that the Board of Directors has recently made the decision to declare a quarterly cash dividend amounting to $0.075 per share. This dividend is set to be paid on December 19 to all stockholders who are on record as of December 5. The Role of NOV in the Energy...

Continue Reading
Enlivex Therapeutics Shares Promising Results for Osteoarthritis

Updated Category News Views 89

Enlivex Therapeutics Reports Positive Efficacy Data from Allocetra Trial Nes-Ziona, Israel – Enlivex Therapeutics Ltd. (NASDAQ: ENLV) has announced encouraging interim results from its Phase I/II Allocetra™ trial focusing on patients with moderate to severe knee osteoarthritis. This randomized multi-country study marks a significant step forward in the company’s...

Continue Reading
Wing Yip Food Holdings Complete First Public Offering Success

Updated Category News Views 108

Wing Yip Food Holdings Completes Successful IPO Wing Yip Food Holdings Group Limited (Nasdaq: WYHG) has successfully concluded its initial public offering (IPO), marking a significant milestone for the company. This meat processing company, operating subsidiaries in mainland China, raised approximately US$8.20 million through the offering of 2,050,000 American Depositary...

Continue Reading
Alkami Technology's Growth: Price Target Raised to $40

Updated Category News Views 30

Alkami Technology's Stock Outlook Enhanced Alkami Technology Inc (NASDAQ: ALKT) has recently captured the attention of investors and analysts alike with its impressive growth trajectory. According to recent reports, the price target for Alkami’s shares has been raised from $35 to $40 by Stephens, indicating a strong belief in the company’s continued success while...

Continue Reading
Confidein Secures $6 Million Seed Funding for Prayer Tech Expansion

Updated Category News Views 283

Confidein's Innovative Prayer Ring Initiative In an inspiring move, Confidein, a dedicated technology company at the intersection of faith and innovation, has successfully concluded a $6 million seed funding round. This funding, driven by influential Christian leaders and leading venture capitalists, sets the stage for a transformative campaign to benefit Christian...

Continue Reading